These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25953424)
1. The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma. Jiang D; Li X; Wang H; Shi Y; Xu C; Lu S; Huang J; Xu Y; Zeng H; Su J; Hou Y; Tan L BMC Cancer; 2015 May; 15():377. PubMed ID: 25953424 [TBL] [Abstract][Full Text] [Related]
2. The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang. Zhang L; Wang Y; Bai G; Zhang J; Yang M; Ma X Tumour Biol; 2015 Dec; 36(12):9277-83. PubMed ID: 26099724 [TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of Kwon D; Yun JY; Keam B; Kim YT; Jeon YK World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma. Wang X; Niu H; Fan Q; Lu P; Ma C; Liu W; Liu Y; Li W; Hu S; Ling Y; Guo L; Ying J; Huang J Oncotarget; 2016 Apr; 7(17):24744-51. PubMed ID: 27013591 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836 [TBL] [Abstract][Full Text] [Related]
6. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition. Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728 [TBL] [Abstract][Full Text] [Related]
7. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma. Moghbeli M; Abbaszadegan MR; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Forghanifard MM Med Oncol; 2013 Jun; 30(2):516. PubMed ID: 23456637 [TBL] [Abstract][Full Text] [Related]
8. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma. Lin X; Xu XY; Chen QS; Huang C Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871 [TBL] [Abstract][Full Text] [Related]
11. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma. Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma. Wang H; Jiang D; Song Q; Xu C; Shi Y; Li X; Huang J; Xu Y; Sujie A; Zeng H; Zhong Y; Tan L; Hou Y Tumour Biol; 2016 Jul; 37(7):9771-9. PubMed ID: 26810066 [TBL] [Abstract][Full Text] [Related]
13. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas. Yang YL; Xu KL; Zhou Y; Gao X; Chen LR Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry. Sato-Kuwabara Y; Neves JI; Fregnani JH; Sallum RA; Soares FA BMC Cancer; 2009 Jan; 9():6. PubMed ID: 19128465 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732 [TBL] [Abstract][Full Text] [Related]
16. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma. Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053 [TBL] [Abstract][Full Text] [Related]
18. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573 [TBL] [Abstract][Full Text] [Related]
19. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran. Anvari K; Sima HR; Seilanian Toussi M; Anvari A; Shahidsales S; Memar B; Aledavoud SA; Forghani MN; Abdollahi A; Ghaffarzadegan K Arch Iran Med; 2017 Apr; 20(4):240-245. PubMed ID: 28412829 [TBL] [Abstract][Full Text] [Related]
20. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma. Kato H; Arao T; Matsumoto K; Fujita Y; Kimura H; Hayashi H; Nishiki K; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T; Okuno K; Shiozaki H; Nishio K Int J Oncol; 2013 Apr; 42(4):1151-8. PubMed ID: 23426935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]